Standardization as a mechanism to improve safety in health care.

[1]  C S Guinane,et al.  Using the PDSA cycle to standardize a quality assurance program in a quality improvement-driven environment. , 1994, The Joint Commission journal on quality improvement.

[2]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[3]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[4]  K E Koch,et al.  Use of standardized screening procedures to identify adverse drug reactions. , 1990, American journal of hospital pharmacy.

[5]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[6]  P. Norton,et al.  Implementing Continuing Education Strategies for Family Physicians to Enhance Asthma Patients' Quality of Life , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

[7]  F. Brancati,et al.  Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. , 1997, Archives of internal medicine.

[8]  S. Weingarten,et al.  A prospective, multicenter study of a pneumonia practice guideline. , 1998, Chest.

[9]  I. Hirsch,et al.  Evidence-based management: using serial firm trials to improve diabetes care quality. , 2002, The Joint Commission journal on quality improvement.

[10]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[11]  R. Resar,et al.  Adverse drug event trigger tool: a practical methodology for measuring medication related harm , 2003, Quality & safety in health care.

[12]  A. Sucov,et al.  Implementation of a disease-specific care plan changes clinician behaviors. , 2000, The American journal of emergency medicine.

[13]  J. Mercy,et al.  Patient safety efforts should focus on medical injuries. , 2002, JAMA.

[14]  G. Fonarow.  Quality Indicators for the Management of Heart Failure in Vulnerable Elders , 2001, Annals of Internal Medicine.

[15]  Lucian L. Leape,et al.  Reducing adverse drug events , 1998 .

[16]  R. Resar,et al.  Medication Safety: One Organization's Approach to the Challenge , 2001 .

[17]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[18]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[19]  R S Evans,et al.  Computerized surveillance of adverse drug events in hospital patients. 1991. , 1991, Quality & safety in health care.

[20]  K. Jones,et al.  Using a revised asthma morbidity index to identify varying patterns of morbidity in U.K. general practices. , 2001, Respiratory medicine.

[21]  G. Fonarow,et al.  Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 3 , 2001, Circulation.